Hemoptysis risk factors: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Removing from Primary care) |
|||
| (9 intermediate revisions by one other user not shown) | |||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} {{SSH}} | {{CMG}}; {{AE}} {{SSH}} | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of hemoptysis include [[Smoking|cigarette smoking]], [[chronic obstructive pulmonary disease]], [[anticoagulant]] medications. Risk factors in the recurrence of hemoptysis include persistent residual mild [[bleeding]] following [[bronchial artery]] [[Therapeutic embolization|embolization]], [[blood transfusion]] before the [[Surgery|procedure]], and [[Aspergillosis|aspergilloma]]. Less common risk factors in the development of hemoptysis include [[congestive heart failure]] and [[mitral regurgitation]]. | |||
==Risk Factors== | ==Risk Factors== | ||
*Common risk factors in the development of hemoptysis include: | * Common risk factors in the development of hemoptysis include:<ref name="LeeKim2015">{{cite journal|last1=Lee|first1=Myoung Kyu|last2=Kim|first2=Sang-Ha|last3=Yong|first3=Suk Joong|last4=Shin|first4=Kye Chul|last5=Kim|first5=Hyun Sik|last6=Yu|first6=Tae-Sun|last7=Choi|first7=Eun Hee|last8=Lee|first8=Won-Yeon|title=Moderate hemoptysis: recurrent hemoptysis and mortality according to bronchial artery embolization|journal=The Clinical Respiratory Journal|volume=9|issue=1|year=2015|pages=53–64|issn=17526981|doi=10.1111/crj.12104}}</ref><ref name="KhalilFedida2015">{{cite journal|last1=Khalil|first1=A.|last2=Fedida|first2=B.|last3=Parrot|first3=A.|last4=Haddad|first4=S.|last5=Fartoukh|first5=M.|last6=Carette|first6=M.-F.|title=Severe hemoptysis: From diagnosis to embolization|journal=Diagnostic and Interventional Imaging|volume=96|issue=7-8|year=2015|pages=775–788|issn=22115684|doi=10.1016/j.diii.2015.06.007}}</ref><ref name="BruzziRémy-Jardin2006">{{cite journal|last1=Bruzzi|first1=John F.|last2=Rémy-Jardin|first2=Martine|last3=Delhaye|first3=Damien|last4=Teisseire|first4=Antoine|last5=Khalil|first5=Chadi|last6=Rémy|first6=Jacques|title=Multi–Detector Row CT of Hemoptysis|journal=RadioGraphics|volume=26|issue=1|year=2006|pages=3–22|issn=0271-5333|doi=10.1148/rg.261045726}}</ref> | ||
**Cigarette smoking | **[[Smoking|Cigarette smoking]] | ||
**Chronic obstructive pulmonary disease | **[[Chronic obstructive pulmonary disease]] | ||
**Anticoagulant medications | **[[Anticoagulant]] medications | ||
*Risk factors in the recurrence of hemoptysis include:<ref name="SakrDutau2010">{{cite journal|last1=Sakr|first1=L.|last2=Dutau|first2=H.|title=Massive Hemoptysis: An Update on the Role of Bronchoscopy in Diagnosis and Management|journal=Respiration|volume=80|issue=1|year=2010|pages=38–58|issn=1423-0356|doi=10.1159/000274492}}</ref> | |||
**Persistent residual mild [[bleeding]] following [[bronchial artery]] [[Therapeutic embolization|embolization]] | |||
**[[Blood transfusion]] before the procedure | |||
**[[Aspergillosis|Aspergilloma]] | |||
* Less common risk factors in the development of hemoptysis include: | |||
**[[Congestive heart failure]] | |||
**[[Mitral regurgitation]] | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Medicine]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Emergency medicine]] | |||
Latest revision as of 22:03, 29 July 2020
|
Hemoptysis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hemoptysis risk factors On the Web |
|
American Roentgen Ray Society Images of Hemoptysis risk factors |
|
Risk calculators and risk factors for Hemoptysis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
Common risk factors in the development of hemoptysis include cigarette smoking, chronic obstructive pulmonary disease, anticoagulant medications. Risk factors in the recurrence of hemoptysis include persistent residual mild bleeding following bronchial artery embolization, blood transfusion before the procedure, and aspergilloma. Less common risk factors in the development of hemoptysis include congestive heart failure and mitral regurgitation.
Risk Factors
- Common risk factors in the development of hemoptysis include:[1][2][3]
- Risk factors in the recurrence of hemoptysis include:[4]
- Persistent residual mild bleeding following bronchial artery embolization
- Blood transfusion before the procedure
- Aspergilloma
- Less common risk factors in the development of hemoptysis include:
References
- ↑ Lee, Myoung Kyu; Kim, Sang-Ha; Yong, Suk Joong; Shin, Kye Chul; Kim, Hyun Sik; Yu, Tae-Sun; Choi, Eun Hee; Lee, Won-Yeon (2015). "Moderate hemoptysis: recurrent hemoptysis and mortality according to bronchial artery embolization". The Clinical Respiratory Journal. 9 (1): 53–64. doi:10.1111/crj.12104. ISSN 1752-6981.
- ↑ Khalil, A.; Fedida, B.; Parrot, A.; Haddad, S.; Fartoukh, M.; Carette, M.-F. (2015). "Severe hemoptysis: From diagnosis to embolization". Diagnostic and Interventional Imaging. 96 (7–8): 775–788. doi:10.1016/j.diii.2015.06.007. ISSN 2211-5684.
- ↑ Bruzzi, John F.; Rémy-Jardin, Martine; Delhaye, Damien; Teisseire, Antoine; Khalil, Chadi; Rémy, Jacques (2006). "Multi–Detector Row CT of Hemoptysis". RadioGraphics. 26 (1): 3–22. doi:10.1148/rg.261045726. ISSN 0271-5333.
- ↑ Sakr, L.; Dutau, H. (2010). "Massive Hemoptysis: An Update on the Role of Bronchoscopy in Diagnosis and Management". Respiration. 80 (1): 38–58. doi:10.1159/000274492. ISSN 1423-0356.